{"filing":{"accession_number":"0001213900-26-073659","cik":"0001840877","ticker":"COCHW","company_name":"Envoy Medical, Inc.","form":"8-K","filing_date":"2026-06-30","report_date":null,"primary_document":"ea0296524-8k_envoy.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026073659/ea0296524-8k_envoy.htm"},"events":[{"id":15083,"run_id":13453,"accession_number":"0001213900-26-073659","anchor_item_number":"1.02","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Envoy Medical terminated its At-The-Market (ATM) equity facility on June 24, 2026, which had authorized the company to offer and sell up to $15 million of common stock. While Item 1.02 covers termination of material definitive agreements, this termination is primarily a financial event reflecting the company's capital-raising strategy rather than a traditional M\u0026A or operational transaction. The press release emphasizes the termination \"reflects Company's confidence in current capital position,\" suggesting improved financial standing. This is material to investors as it affects the company's available financing options and capital structure, but does not fit neatly into the specific financial categories (debt_issuance, dilutive_issuance, etc.) since it represents the *removal* of a financing facility rather than a new obligation or issuance.","company_name":"Envoy Medical, Inc.","ticker":"COCHW","filing_date":"2026-06-30","form":"8-K","submitted_at":null,"items":[{"id":12716,"accession_number":"0001213900-26-073659","item_number":"1.02","item_title":"Termination of a Material Definitive Agreement","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Envoy Medical terminated its At-The-Market (ATM) equity facility on June 24, 2026, which had authorized the company to offer and sell up to $15 million of common stock. While Item 1.02 covers termination of material definitive agreements, this termination is primarily a financial event reflecting the company's capital-raising strategy rather than a traditional M\u0026A or operational transaction. The press release emphasizes the termination \"reflects Company's confidence in current capital position,\" suggesting improved financial standing. This is material to investors as it affects the company's available financing options and capital structure, but does not fit neatly into the specific financial categories (debt_issuance, dilutive_issuance, etc.) since it represents the *removal* of a financing facility rather than a new obligation or issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T02:24:40.307210+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12716,"accession_number":"0001213900-26-073659","item_number":"1.02","item_title":"Termination of a Material Definitive Agreement","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Envoy Medical terminated its At-The-Market (ATM) equity facility on June 24, 2026, which had authorized the company to offer and sell up to $15 million of common stock. While Item 1.02 covers termination of material definitive agreements, this termination is primarily a financial event reflecting the company's capital-raising strategy rather than a traditional M\u0026A or operational transaction. The press release emphasizes the termination \"reflects Company's confidence in current capital position,\" suggesting improved financial standing. This is material to investors as it affects the company's available financing options and capital structure, but does not fit neatly into the specific financial categories (debt_issuance, dilutive_issuance, etc.) since it represents the *removal* of a financing facility rather than a new obligation or issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T02:24:40.307210+00:00","company_name":"Envoy Medical, Inc.","ticker":"COCHW","filing_date":"2026-06-30"}]}